Company: DMAAR
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076681
Chunk: 32

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 32
---
 and monitor shareholder value and determine
the most effective strategy of investment with the Trust Account funds while maintaining compliance with the trust agreement. General
and administrative costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete
a Business Combination within the Combination Period. The CODM also reviews general and administrative costs to manage, maintain and enforce
all contractual agreements to ensure costs are aligned with all agreements and budget.

NOTE 10 — SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions
that occurred after the unaudited balance sheets and through the date that the financial statements were issued. Based upon this review,
the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

18

Item 2. Management’s Discussion and Analysis of Financial
Condition and Results of Operations.

References in this report to “we,”
“us,” “our” or the “Company” refer to Drugs Made In America Acquisition Corp. References to our “management”
or our “management team” refer to our officers and directors, and references to the “sponsor” refer to Drugs Made
In America Acquisition LLC. The following discussion and analysis of the Company’s financial condition and results of operations
should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this report. Certain information
contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties

Special Note Regarding Forward-Looking Statements

Some of the statements contained in this report
may constitute “forward-looking statements” for purposes of the federal securities laws. All statements, other than statements
of historical fact included in this report including, without limitation, statements in this “Management’s Discussion and
Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and
the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,”
“anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions
are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance,
but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events,
performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For
information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking